StockData

Orchestra BioMed Holdings, Inc. (OBIO) stock

OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30
$6.97−0.15 (-2.11%)

Close on Nov 17, 2026Market cap $418.93MP/E –Yield –

Orchestra BioMed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Orchestra BioMed's price to sales ratio was 11.3× on Nov 11, 2026, against 106.6× a year earlier. Over the last 4 years it ranged from 6.8× to 131.6×, with a median of 58.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.3×−71.9
2025Dec 31, 202583.2×+25.8
2024Dec 31, 202457.3×−33.3
2023Dec 29, 202390.6×–

More Orchestra BioMed figures

See a number that looks wrong?